Zurich Cantonal Bank’s Audentes Therapeutics, Inc BOLD Stock Holding History

Zurich Cantonal Bank’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,990	Closed	-$179K	–	2621
2019 Q4	$179K	Hold	2,990	–	–	﹤0.01%	1403
2019 Q3	$84K	Hold	2,990	–	–	﹤0.01%	1714
2019 Q2	$113K	Buy	2,990 +1,005	+51%	+$38.6K	﹤0.01%	1549
2019 Q1	$77K	Hold	1,985	–	–	﹤0.01%	1742
2018 Q4	$42K	Hold	1,985	–	–	﹤0.01%	2141
2018 Q3	$79K	Hold	1,985	–	–	﹤0.01%	1868
2018 Q2	$76K	Buy	1,985 +1,119	+129%	+$41.4K	﹤0.01%	1841
2018 Q1	$26K	Buy	+866	New	+$29.3K	﹤0.01%	2352

Zurich Cantonal Bank's BOLD Position: Q1 2020 in Review

Zurich Cantonal Bank sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 2,990 shares — an estimated $179K sold.

Zurich Cantonal Bank first reported a position in BOLD in Q1 2018 and held it in 8 quarters. The position peaked at $179K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Zurich Cantonal Bank reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Zurich Cantonal Bank sold 2,990 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $179K.
Zurich Cantonal Bank first reported a position in Audentes Therapeutics, Inc in Q1 2018 and held it in 8 quarters.
Zurich Cantonal Bank's Audentes Therapeutics, Inc position peaked at $179K in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Zurich Cantonal Bank's 13F filing for Q1 2020, filed 6 May 2020.